110 patients with severe refractory epilepsy, who previously had not perceived any beneficial effects from at least three different AEDs, fulfilled the study inclusion and exclusion criteria.

ganaxolone in treating refractory status epilepticus (RSE). The trial, which assessed patients whose seizures were ...

Patna: International Epilepsy Day, observed on the second Monday of Feb since 2015, aims to educate the public, break the ...

This breakthrough follows GW Pharmaceuticals' $7.2 billion acquisition, highlighting the potential of cannabis-based epilepsy treatments. Argent BioPharma's CannEpil® is poised to follow a similar ...

While VNS can offer great relief, it is important to note that it does not cure epilepsy. The device helps manage seizures ...